Press Releases

Distinct Alternative to Surgery, Radiological Approaches and Power Morcellation, for the Treatment of Symptomatic Uterine Fibroids. REDWOOD CITY, CA – October 22, 2014 – Gynesonics, Inc., a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic

Veteran Medical Device Executive with Expertise in Clinical, Reimbursement, Sales, Marketing REDWOOD CITY, CA – August 7, 2014 – Gynesonics, Inc., a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced it has

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Gynesonics, Inc., a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced the first treatment of a patient in Cologne, Germany, using the Company’s newly-designed

The Only System to Combine and Integrate Ultrasound Imaging with Radiofrequency Ablation in a Single Device June 12, 2014 10:00 AM Eastern Daylight Time REDWOOD CITY, Calif.--(BUSINESS WIRE)--Gynesonics, Inc., a women’s healthcare company that has developed a minimally invasive device

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Gynesonics, Inc., a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that it has named veteran medical device executive Christopher M. Owens as President and Chief Executive

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Gynesonics, Inc., a women’s healthcare company focused on minimally invasive solutions for symptomatic uterine fibroids, announced today a Series D financing led by HBM Partners based in Switzerland. The $21 million financing included additional new investor